Both positive regulation of growth and regulation of growth pathways capture oncogenic signaling (e.g., EGFR, KRAS, and Hippo/YAP) that drive proliferation, metabolic adaptation, and immune evasion in lung cancer [82]. This evidence concerns the gene KRAS and lung cancer.